Brokerages Set Cerevel Therapeutics Holdings, Inc (NASDAQ:CERE) Target Price at $34 80 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE – Get Free Report) hit a new 52-week low on Friday after Morgan Stanley lowered their price target on the stock from $46.00 to $42.00. Morgan Stanley currently has an overweight rating on the stock. Cerevel Therapeutics traded as low as $22.58 and last traded at $22.75, with a volume […]
Cerevel Therapeutics (NASDAQ:CERE) Sets New 12-Month Low Following Analyst Downgrade theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Cerevel Therapeutics (NASDAQ:CERE – Get Free Report) announced its quarterly earnings data on Wednesday. The biotechnology company reported ($0.63) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.65) by $0.02, Briefing.com reports. During the same quarter last year, the firm posted ($0.61) earnings per share. Cerevel Therapeutics Price Performance CERE traded […]
Cerevel Therapeutics (NASDAQ:CERE) Posts Quarterly Earnings Results, Beats Estimates By $0 02 EPS themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.